Skip to content
AwardedCzechiaGoodsCZK 8,929,000

Dodávky léků - KINERET 2026

Published
Published 27 March 2026
Deadline
Closed 27 April 2026

Overview

The Rheumatology Institute procured continuous supplies of the drug anakinra (KINERET) with an estimated value of 8.93 million CZK. The contract was awarded to PHARMOS, a.s. on 7 May 2026 for the full estimated value.

Key details

Country
Czechia
Status
Awarded
Category
Goods
Estimated value
CZK 8,929,000
Procedure
Open
Published
27 March 2026
Deadline
Closed
Classification (CPV)
Antineoplastic and immunomodulating agents

Award outcome

Awarded value
CZK 8,929,000
Award date
7 May 2026
Contract period
— → 21 April 2029
Winner
  • PHARMOS, a.s.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    9 June 2026

  2. Contract Notice

    27 March 2026

Contracting authority

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Dodávky léků - KINERET 2026 — won by PHARMOS, a.s. — Skim